These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17433035)

  • 1. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound.
    Emoto M; Tachibana K; Iwasaki H; Kawarabayashi T
    Cancer Sci; 2007 Jun; 98(6):929-35. PubMed ID: 17433035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel chemoembolization using calcium-phosphate ceramic microsphere incorporating TNP-470, an anti-angiogenic agent.
    Emoto M; Naganuma Y; Choijamts B; Ohno T; Yoshihisa H; Kanomata N; Kawarabayashi T; Aizawa M
    Cancer Sci; 2010 Apr; 101(4):984-90. PubMed ID: 20109162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft.
    Choijamts B; Naganuma Y; Nakajima K; Kawarabayashi T; Miyamoto S; Tachibana K; Emoto M
    Cancer Sci; 2011 Feb; 102(2):452-9. PubMed ID: 21205068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
    Naganuma Y; Choijamts B; Shirota K; Nakajima K; Ogata S; Miyamoto S; Kawarabayashi T; Emoto M
    Cancer Sci; 2011 Aug; 102(8):1545-52. PubMed ID: 21631643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of TNP-470 in combination with BCNU on tumor growth of human glioblastoma xenografts.
    Yao D; Zhao H; Zhang F; Chen J; Jiang X; Zhu X
    J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):757-61. PubMed ID: 21181367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Chemoembolization by Anti-angiogenic Calcium-Phosphate Ceramic Microspheres Targeting the Vascular Heterogeneity of Cancer Xenografts.
    Emoto M; Yoshihisa H; Yano K; Choijamts B; Tsugu H; Tachibana K; Aizawa M
    Anticancer Res; 2015 Sep; 35(9):4757-64. PubMed ID: 26254366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
    J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
    Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
    Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470.
    Pu YS; Do KA; Luo W; Logothetis CJ; Lin SH
    Anticancer Drugs; 2002 Aug; 13(7):743-9. PubMed ID: 12187331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.
    Shusterman S; Grupp SA; Maris JM
    Med Pediatr Oncol; 2000 Dec; 35(6):673-6. PubMed ID: 11107144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.
    Landuyt W; Ahmed B; Nuyts S; Theys J; Op de Beeck M; Rijnders A; Anné J; van Oosterom A; van den Bogaert W; Lambin P
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):443-50. PubMed ID: 11173139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas.
    Ueda N; Kamata N; Hayashi E; Yokoyama K; Hoteiya T; Nagayama M
    Oral Oncol; 1999 Nov; 35(6):554-60. PubMed ID: 10705089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effect of angiogenesis inhibitor TNP-470 and 5-FU combined therapy on human gastric cancer xenograft.
    Nishimura K; Ohno M; Chung-Kang C; Kuroda Y
    Hepatogastroenterology; 2008; 55(82-83):774-8. PubMed ID: 18613452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice.
    Bernsen HJ; Rijken PF; Peters H; Bakker H; van der Kogel AJ
    J Neurooncol; 1998 May; 38(1):51-7. PubMed ID: 9540057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
    Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
    Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental therapy with angiogenesis inhibitor TNP-470 on human ovarian cancer transplanted subcutaniously in nude mice].
    Kong H; Jin Z; Yao M
    Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):556-8. PubMed ID: 12411020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.